Steven S. Matsumoto

Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.

D A Carson, Jonathan Kaye, Steven S. Matsumoto et al. · Proceedings of the National Academy of Sciences · 1979 · 179 citations · Full text

Pharmacy, Oncology, Toxicology +14

Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin

Yogesh S. Sanghvi, Birendra K. Bhattacharya, Ganesh D. Kini et al. · Journal of Medicinal Chemistry · 1990 · 94 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Antitumor and antiviral activity of synthetic .alpha.- and .beta.-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosides

Yogesh S. Sanghvi, Steven B. Larson, Steven S. Matsumoto et al. · Journal of Medicinal Chemistry · 1989 · 72 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.

Steven S. Matsumoto, John Yu, Alice L. Yu · The Journal of Immunology · 1983 · 47 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics

Christina L. Zuch de Zafra, Vito G. Sasseville, Steven S. Matsumoto et al. · Regulatory Toxicology and Pharmacology · 2017 · 39 citations

Medicine, Immunology, Ophthalmology +12